Correlation Between KTRA Old and Cellectar Biosciences
Can any of the company-specific risk be diversified away by investing in both KTRA Old and Cellectar Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KTRA Old and Cellectar Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KTRA Old and Cellectar Biosciences, you can compare the effects of market volatilities on KTRA Old and Cellectar Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KTRA Old with a short position of Cellectar Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of KTRA Old and Cellectar Biosciences.
Diversification Opportunities for KTRA Old and Cellectar Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between KTRA and Cellectar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding KTRA Old and Cellectar Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectar Biosciences and KTRA Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KTRA Old are associated (or correlated) with Cellectar Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectar Biosciences has no effect on the direction of KTRA Old i.e., KTRA Old and Cellectar Biosciences go up and down completely randomly.
Pair Corralation between KTRA Old and Cellectar Biosciences
If you would invest 24.00 in Cellectar Biosciences on December 20, 2024 and sell it today you would earn a total of 15.00 from holding Cellectar Biosciences or generate 62.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
KTRA Old vs. Cellectar Biosciences
Performance |
Timeline |
KTRA Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Cellectar Biosciences |
KTRA Old and Cellectar Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with KTRA Old and Cellectar Biosciences
The main advantage of trading using opposite KTRA Old and Cellectar Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KTRA Old position performs unexpectedly, Cellectar Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectar Biosciences will offset losses from the drop in Cellectar Biosciences' long position.KTRA Old vs. SAB Biotherapeutics | KTRA Old vs. Theriva Biologics | KTRA Old vs. Lisata Therapeutics | KTRA Old vs. Dyadic International |
Cellectar Biosciences vs. Monopar Therapeutics | Cellectar Biosciences vs. Pulmatrix | Cellectar Biosciences vs. Tenax Therapeutics | Cellectar Biosciences vs. Capricor Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |